Alison Moore Allogene Therapeutics, Inc. (ALLO) insider trading activity

Alison Moore is Chief Technical Officer of Allogene Therapeutics, Inc.. Currently has a direct ownership of 672,731 shares of ALLO, which is worth approximately $1.09 Million. The most recent transaction as insider was on Mar 22, 2023, when has been sold 558,094 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 673K

0% 3M change

0% 12M change

Total Value Held $1.09 Million

ALISON MOORE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 22 2023	BUY Grant, award, or other acquisition	-	558,094 Added 45.34%	672,731 Common Stock
Mar 14 2023	SELL Payment of exercise price or tax liability	$46,014 $5.51 p/Share	8,351 Reduced 6.79%	114,637 Common Stock
Mar 15 2022	SELL Open market or private sale	$66,366 $7.63 p/Share	8,698 Reduced 6.74%	120,430 Common Stock
Mar 26 2021	BUY Grant, award, or other acquisition	-	24,866 Added 16.33%	127,440 Common Stock
Mar 15 2021	SELL Open market or private sale	$235,095 $38.14 p/Share	6,164 Reduced 5.67%	102,574 Common Stock
Oct 13 2020	SELL Open market or private sale	$463,302 $42.0 p/Share	11,031 Reduced 9.24%	108,370 Common Stock
Oct 13 2020	BUY Exercise of conversion of derivative security	$25,040 $2.27 p/Share	11,031 Added 8.46%	119,401 Common Stock
Oct 12 2020	SELL Open market or private sale	$1,017,786 $42.0 p/Share	24,233 Reduced 18.27%	108,370 Common Stock
Oct 12 2020	BUY Exercise of conversion of derivative security	$55,009 $2.27 p/Share	24,233 Added 15.45%	132,603 Common Stock
Oct 09 2020	SELL Open market or private sale	$1,619,869 $41.0 p/Share	39,509 Reduced 26.72%	108,370 Common Stock
Oct 09 2020	BUY Exercise of conversion of derivative security	$68,552 $2.27 p/Share	30,199 Added 16.96%	147,879 Common Stock
Oct 08 2020	SELL Open market or private sale	$207,665 $41.0 p/Share	5,065 Reduced 4.13%	117,680 Common Stock
Oct 08 2020	BUY Exercise of conversion of derivative security	$11,498 $2.27 p/Share	5,065 Added 3.96%	122,745 Common Stock
Oct 06 2020	SELL Open market or private sale	$1,782,960 $40.0 p/Share	44,574 Reduced 27.47%	117,680 Common Stock
Oct 06 2020	BUY Exercise of conversion of derivative security	$80,049 $2.27 p/Share	35,264 Added 17.92%	161,536 Common Stock

Also insider at

CDXS

CODEXIS, INC. Healthcare

Chief Technical Officer

RTVA

Artiva Biotherapeutics, Inc.

Alison Moore

Chief Technical Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Allogene Therapeutics, Inc.

Track Activities on ALLO

Account